Rinaldo Roberto de Jesus Guirro

Ribeirao Preto, São Paulo, Brazil

About Rinaldo Roberto de Jesus Guirro


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Rinaldo Roberto de Jesus Guirro


During the past decade, Rinaldo Roberto de Jesus Guirro conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
2023-12-29
2026-01-30
Suspended
560

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Rinaldo Roberto de Jesus Guirro


According to Clinical.Site data, the most researched conditions in "Rinaldo Roberto de Jesus Guirro" are "Diabetes Mellitus" (1 trials), "Electric Stimulation Therapy" (1 trials), "Exercise Therapy" (1 trials), "Healthy Individuals" (1 trials) and "Muscle Strength" (1 trials). Many other conditions were trialed in "Rinaldo Roberto de Jesus Guirro" in a lesser frequency.

Clinical Trials Intervention Types at Rinaldo Roberto de Jesus Guirro


Most popular intervention types in "Rinaldo Roberto de Jesus Guirro" are "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Control group" (1 trials), "NMES" (1 trials), "Vascular Occlusion" (1 trials), "cryotherapy by immersion" (1 trials) and "sensorio-motor training" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Rinaldo Roberto de Jesus Guirro


The vast majority of trials in "Rinaldo Roberto de Jesus Guirro" are 1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Rinaldo Roberto de Jesus Guirro


Currently, there are NaN active trials in "Rinaldo Roberto de Jesus Guirro". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rinaldo Roberto de Jesus Guirro, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Rinaldo Roberto de Jesus Guirro, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status